JOIN US
Liquid Biopsy in Advanced
Breast Cancer: Stay Up to Date

When a liquid biopsy report identifies a targetable driver,
treatment decisions are clear. When there is no driver identified,
the next steps are more uncertain. Expert speakers will present
their perspectives on liquid biopsy for treatment selection in
breast cancer and discuss emerging biomarker ctDNA tumor
fraction reported on Foundation Medicine’s liquid biopsy test